Myriad Genetics
MYGN
#8041
Rank
A$0.55 B
Marketcap
A$5.81
Share price
7.25%
Change (1 day)
-48.06%
Change (1 year)

Earnings for Myriad Genetics (MYGN)

Earnings in 2026 (TTM): -A$0.59 Billion

According to Myriad Genetics's latest financial reports the company's current earnings are A$0.82 Billion. In 2025 the company made an earning of -A$0.54 Billion a decrease over its 2024 earnings that were of -A$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Myriad Genetics from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.59 Billion8.28%
2025 -A$0.54 Billion218.91%
2024 -A$0.17 Billion-53.49%
2023 -A$0.37 Billion88.72%
2022 -A$0.2 Billion172.08%
2021 -A$70.85 Million
2019 -A$36.9 Million-175.14%
2018 A$49.1 M-70.81%
2017 A$0.16 B22.22%
2016 A$0.13 B-38.8%
2015 A$0.22 B-6.12%
2014 A$0.23 B-41.07%
2013 A$0.40 B46.67%
2012 A$0.27 B15.84%
2011 A$0.23 B17.6%
2010 A$0.20 B-15.96%
2009 A$0.24 B
2007 -A$58.47 Million40.96%
2006 -A$41.48 Million
2003 -A$48.17 Million34.8%
2002 -A$35.74 Million89.21%
2001 -A$18.89 Million3.93%
2000 -A$18.18 Million21.76%
1999 -A$14.93 Million-25.61%
1998 -A$20.07 Million38.83%
1997 -A$14.45 Million-24.26%
1996 -A$19.08 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Abbott Laboratories
ABT
A$11.41 B-2,208.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
-A$0.26 Billion-52.79%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.54 B-199.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-A$49.06 Million-90.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
A$0.31 B-157.59%๐Ÿ‡บ๐Ÿ‡ธ USA